Plenary Sessions-30/04/2021

Friday, April 30th, 2021

10:30 – 10:45

Congress Opening: Anna Falanga, Benjamin Brenner, Alok A Khorana

 10:45 – 13:00

Plenary Session 1: New Insights In Prevalence of Cancer-Associated Thrombosis

Chairs: H. Liebman (USA), M. Aapro (Switzerland)

PL-01 -Screening for Occult Cancer: Where Are We in 2020?
L. Jara-Palomares (Spain)

PL-02 - An overview of thrombotic complications of old and new anti-cancer drugs
M. Levi (The Netherlands)

PL-03 - Impact of arterial thrombosis in cancer patients
S.C. Cannegieter (The Netherlands)

PL-04 - Cancer associated thrombosis in pediatric setting
G. Kenet (Israel)

Selected Abstract

OC-01 - Incidence, Predictors and Clinical Outcomes of Venous Thromboembolism in Patients with Newly Diagnosed Pancreatic Ductal Adenocarcinoma: Results of the Prospective BACAP-VTE Study
C. Frere, B. Bournet, S. Gourgou, J. Fraisse, C. Canivet, J.M. Connors, L. Buscail, D. Farge, on behalf of the Groupe Francophone Thrombose et Cancer and the BACAP Consortium (France, Canada)

OC-02 - Risk of venous thromboembolism in cancer patients: a cohort study
F. Mulder,E. Horváth-Puhó, N. van Es, H.W.M. van Laarhoven, L. Pedersen, H.R. Büller, H.T. Sørensen (The Netherlands, Denmark)


13:00 - 14:00

Lunch Sessions

14:00 - 14:20

Coffee and pastries

14:20 – 16:35

Plenary Session 2: Biomarkers in CAT and cancer progression

Chairs: N. Mackman (USA), A.K. Olsson (Sweden)

PL-05 - Impact of preclinical variables on thrombotic biomarkers levels in cancer
A. Lee (Canada)

PL-06 - Biomarkers in cancer VTE: Data from the AVERT study
N. Key (USA)

P-L07 - Thrombotic biomarkers in occult cancer and cancer risk prediction
M. Marchetti (Italy)

PL08 - Genes and proteins associated with CAT risk
H Versteeg (The Netherlands)

PL-09 - Role of NETs in cancer associated-thrombosis
S. Zeerleder (Switzerland)

Selected Abstract

OC-03- Biomarkers of venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis (HISPALIS- Study).
R. Otero Candelera, V. Sánchez López, E. Arellano Orden,  J. Oto Martinez, A. Solier-López, S. Marín Romero, L. Jara Palomares, T. Elias Hernández, M.I. Asencio Cruz, I. Blasco-Esquivias, M. Rodriguez de la Borbolla, J.M. Sánchez Díaz, F.J. Rodriguez Martorell, P. Medina Badenes (Spain)

OC-04 - Proteomic profiling in cancer-associated VTE
M. Panova-Noeva, A. Schulz, T. Köck, V. ten Cate, B. Wagner, S. Rapp, M. Lenz, A. Zink, M. Ghadessi, S. Konstantinides, H. ten Cate, S. Heitmeier, P. Wild (Germany, The Netherlands)

16:35 - 17:05

Coffee break

17:05 – 18:05

Roundtable: Risk assessment models for VTE in cancer

Chairs: P. Angchaisuksiri (Thailand), C. Ay (Austria)

Introduction: Overview of risk assessment models for VTE in ambulatory patients with cancer
G. Gerotziafas (France)

Discussants: A. Falanga (Italy), N. Van Es (The Netherlands), A.A. Khorana (USA), M.B. Donati (Italy), G. Gerotziafas (France)

 18.05 – 19.00

Special Lecture

Introduction to Lecture
C. Rizzi (Italy)

Are the new technologies useful to medicine or the opposite? 
A. Remuzzi (Italy)

 19:00 - 20:00

Welcome Reception